After years of GLP-1 ads spotlighting anonymous bellies and dancing commercial actors, telehealth firm Ro is ushering in ...

Scientists are developing a new drug aimed at tackling obesity in cats and dogs, as rising numbers of pets face serious ...

No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish ...

Patients' vision loss, which is rare according to a new study, is also the subject of multiple lawsuits, including two filed ...

Vicky is accused of managing an elaborate international criminal conspiracy involving the supply of counterfeit ...

Women using Ozempic are reporting rare side effects affecting their intimate areas, including dryness and discomfort. Experts advise consulting a doctor if symptoms appear.

As Novo Nordisk's sales of its blockbuster weight-loss drug Wegovy boomed, the Danish drugmaker raced to expand manufacturing ...

Serena Williams recently detailed her weight loss journey, sharing that she lost 31 pounds with the assistance of a GLP-1 medication.

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.

Novo Nordisk raced to meet demand for its weight-loss drug Wegovy and almost doubled its workforce over five years. Now, the ...

A WOMAN has shared her three go-to recipe which help her stay slim without resorting to Ozempic. Gina Drewalowski, who is on ...

A retrospective macro-study revealed that the use of GLP-1 agonists is associated with a reduction in the overall risk of cancer among obese or overweight patients ...